MXPA04006088A - Polimorfo de sulfato de hidrogeno de clopidogrel. - Google Patents

Polimorfo de sulfato de hidrogeno de clopidogrel.

Info

Publication number
MXPA04006088A
MXPA04006088A MXPA04006088A MXPA04006088A MXPA04006088A MX PA04006088 A MXPA04006088 A MX PA04006088A MX PA04006088 A MXPA04006088 A MX PA04006088A MX PA04006088 A MXPA04006088 A MX PA04006088A MX PA04006088 A MXPA04006088 A MX PA04006088A
Authority
MX
Mexico
Prior art keywords
clopidogrel hydrogensulfate
polymorphs
clopidogrel
hydrogensulfate
iii
Prior art date
Application number
MXPA04006088A
Other languages
English (en)
Inventor
Lidor-Hadas Ramy
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/074,409 external-priority patent/US6767913B2/en
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of MXPA04006088A publication Critical patent/MXPA04006088A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Liquid Crystal Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

Se proveen nuevas Formas III, IV, V y VI cristalinas del sulfato de hidrogeno de clopidogrel y la forma amorfa de sulfato de hidrogeno de clopidogrel, asi como sus composiciones farmaceuticas, y metodos de tratamiento con tales composiciones. Tambien se proporcionan procesos novedosos para la preparacion de la Forma I, la Forma II, la Forma III, la Forma IV, la Forma V, la Forma VI y la forma amorfa de sulfato de hidrogeno de clopidogrel.
MXPA04006088A 2001-12-18 2002-12-18 Polimorfo de sulfato de hidrogeno de clopidogrel. MXPA04006088A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US34244001P 2001-12-18 2001-12-18
US34235101P 2001-12-21 2001-12-21
US34818202P 2002-01-11 2002-01-11
US10/074,409 US6767913B2 (en) 2001-12-18 2002-02-12 Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US35915702P 2002-02-21 2002-02-21
PCT/US2002/040679 WO2003051362A2 (en) 2001-12-18 2002-12-18 Polymorphs of clopidogrel hydrogensulfate

Publications (1)

Publication Number Publication Date
MXPA04006088A true MXPA04006088A (es) 2004-09-27

Family

ID=27536010

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04006088A MXPA04006088A (es) 2001-12-18 2002-12-18 Polimorfo de sulfato de hidrogeno de clopidogrel.

Country Status (18)

Country Link
EP (1) EP1467735B1 (es)
JP (2) JP2005514387A (es)
KR (1) KR100839136B1 (es)
CN (1) CN1620293A (es)
AT (1) ATE417051T1 (es)
AU (1) AU2002366383B2 (es)
CA (1) CA2470479A1 (es)
DE (1) DE60230327D1 (es)
ES (1) ES2316650T3 (es)
HR (1) HRP20040647A2 (es)
HU (1) HUP0402485A3 (es)
IL (1) IL162461A0 (es)
IS (1) IS7319A (es)
MX (1) MXPA04006088A (es)
NO (1) NO20043038L (es)
PL (1) PL370802A1 (es)
PT (1) PT1467735E (es)
WO (1) WO2003051362A2 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ297472B6 (cs) * 2002-08-27 2006-12-13 Zentiva, A.S. Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I
GB2393181A (en) * 2002-09-19 2004-03-24 Cipla Ltd Amorphous clopidogrel
ITMI20022228A1 (it) * 2002-10-21 2004-04-22 Dinamite Dipharma S P A Sali di clopidogrel con acidi alchil-solforici.
WO2004048385A2 (en) * 2002-11-28 2004-06-10 Instytut Farmaceutyczny A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate
US20060100231A1 (en) * 2003-03-10 2006-05-11 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
WO2004081016A1 (en) 2003-03-12 2004-09-23 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
HU0302029D0 (en) * 2003-07-02 2003-09-29 Egyt Gyogyszervegyeszeti Gyar Amorphous form of an anticoagulant agent
EA010684B1 (ru) * 2003-07-02 2008-10-30 Эгиш Дьёдьсердьяр Рт. Способ получения кристаллического полиморфа ингибитора агрегации тромбоцитов
WO2005003138A2 (en) * 2003-07-02 2005-01-13 EGIS Gyógyszergyár Rt. Process for the preparation of amorphous form of a platelet aggregation inhibitor drug
DE10337773A1 (de) * 2003-08-13 2005-03-24 Krka Tovarna Zdravil, D.D. Kristallisation von festen Formen von Clopidogrel-Additionssalzen
CA2676121A1 (en) 2003-11-03 2005-07-14 Cadila Healthcare Limited Processes for preparing different forms of (s)-(+)-clopidogrel bisulfate
BRPI0418726A (pt) * 2004-04-09 2007-09-11 Hanmi Pharm Ind Co Ltd naftalenossulfonato de clopidogrel cristalino ou hidrato do mesmo, método para sua preparação e composição farmacêutica contendo o mesmo
SI1740593T1 (sl) 2004-04-19 2016-08-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo polimorfne oblike I klopidogrel hidrogen sulfata
BRPI0510008A (pt) * 2004-04-20 2007-09-18 Sanofi Aventis sal de clopidogrel e formas polimórficas deste
EP1756116A1 (en) * 2004-04-20 2007-02-28 Sanofi-Aventis Polymorphic forms of methyl(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h) acetate hydrobromide, clopidrogel hydrobromide
EP1750701A1 (en) * 2004-06-01 2007-02-14 IVAX Pharmaceuticals s.r.o. Amorphous clopidogrel hydrochloride and its antithrombotic use
EP1693375A1 (en) * 2005-02-21 2006-08-23 KRKA, tovarna zdravil, d.d., Novo mesto Process for preparing clopidrogel hydrogen sulfate of form I
KR20070009851A (ko) * 2005-07-14 2007-01-19 씨제이 주식회사 클로피도그렐 황산수소염 함유 약학 조성물
US20090093635A1 (en) * 2006-03-09 2009-04-09 Sandor Garadnay PROCESS FOR MAKING POLYMORPH FROM I OF (S) - (+) -METHYL-ALPHA- (2-CHLOROPHENYL) -6, 7-DYHIDRO-THIENO- [3, 2-c] PYRIDINE-5 (4H) -ACETATE HYDROGEN SULFATE
SI22383A (sl) * 2006-09-22 2008-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze klopidogrela in nove oblike njegovih farmacevtsko sprejemljivih soli
HUP0600839A3 (en) * 2006-11-14 2008-09-29 Egis Gyogyszergyar Nyrt Solid pharmaceutical composition containing polymorph i of clopidogrel hydrogensulfate and process for the preparation thereof
KR101464482B1 (ko) * 2007-05-08 2014-11-26 경동제약 주식회사 클로피도그렐 황산수소염을 함유하는 약학적 조성물 및 그제조방법
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
KR101130445B1 (ko) * 2009-10-29 2012-03-27 동아제약주식회사 클로피도그랠 황산수소염 ⅰ형 제조방법
CN101962387B (zh) * 2010-09-13 2013-01-30 成都雅途生物技术有限公司 一种新结晶形态的氯吡格雷硫酸氢盐及其制备方法
CN102358743A (zh) * 2011-11-05 2012-02-22 江南大学 一种制备无定形氯吡格雷硫酸氢盐的简便方法
CN103006599A (zh) * 2012-12-31 2013-04-03 广州白云山天心制药股份有限公司 含氯化钠药物载体的抗凝血片剂及其制备方法
CN103408567B (zh) * 2013-07-18 2016-12-28 浙江普洛医药科技有限公司 一种制备硫酸氢氯吡格雷晶型ⅰ的方法
CN104610274B (zh) * 2013-11-05 2017-04-19 亚宝药业集团股份有限公司 一种i型氯吡格雷硫酸氢盐的制备方法
TWI788702B (zh) 2013-11-15 2023-01-01 美商阿克比治療有限公司 {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式，其組合物及用途
CN104045653A (zh) * 2014-07-15 2014-09-17 苏州天马精细化学品股份有限公司 一种硫酸氢氯吡格雷的纯化方法
KR101710922B1 (ko) 2015-06-03 2017-02-28 경동제약 주식회사 클로피도그렐 황산염 결정형 i형의 제조방법
CN107163060B (zh) * 2017-05-24 2021-03-02 常州制药厂有限公司 一种硫酸氢氯吡格雷晶型ii制备方法
CN107337683B (zh) * 2017-08-16 2019-08-16 中荣凯特（北京）生物科技有限公司 一种噻吩并吡啶类衍生物硫酸氢盐的晶型ⅱ及其制备方法和应用
WO2020013305A1 (ja) * 2018-07-12 2020-01-16 有機合成薬品工業株式会社 クロピドグレル硫酸塩のｉ型結晶の製造方法
KR102220480B1 (ko) * 2019-02-13 2021-02-25 한국바이오켐제약 주식회사 클로피도그렐황산염의 제조방법 및 이를 포함하는 약학제제

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2664276B1 (fr) * 1990-07-04 1992-10-23 Sanofi Sa Derive thienyl-2 glycidique, son procede de preparation et son utilisation comme intermediaire de synthese.
US5576328A (en) * 1994-01-31 1996-11-19 Elf Sanofi Method for the secondary prevention of ischemic events
FR2751540B1 (fr) * 1996-07-26 1998-10-16 Sanofi Sa Composition pharmaceutique antithrombotique
FR2769313B1 (fr) * 1997-10-06 2000-04-21 Sanofi Sa Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
FR2779726B1 (fr) * 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
WO2004052966A1 (en) * 2002-12-09 2004-06-24 Hetero Drugs Limited A novel polymorph of clopidogrel hydrogen sulfate

Also Published As

Publication number Publication date
JP2009108107A (ja) 2009-05-21
EP1467735A4 (en) 2005-11-23
JP2005514387A (ja) 2005-05-19
CA2470479A1 (en) 2003-06-26
WO2003051362A3 (en) 2003-08-07
PT1467735E (pt) 2009-03-10
PL370802A1 (en) 2005-05-30
KR20040066917A (ko) 2004-07-27
HUP0402485A3 (en) 2008-10-28
HUP0402485A2 (hu) 2005-04-28
KR100839136B1 (ko) 2008-06-20
HRP20040647A2 (en) 2005-04-30
CN1620293A (zh) 2005-05-25
WO2003051362A2 (en) 2003-06-26
ATE417051T1 (de) 2008-12-15
IS7319A (is) 2004-06-16
IL162461A0 (en) 2005-11-20
AU2002366383B2 (en) 2007-06-14
ES2316650T3 (es) 2009-04-16
DE60230327D1 (de) 2009-01-22
AU2002366383A1 (en) 2003-06-30
EP1467735B1 (en) 2008-12-10
NO20043038L (no) 2004-09-09
EP1467735A2 (en) 2004-10-20

Similar Documents

Publication Publication Date Title
IL162461A0 (en) Polymorphs of clopidogrel hydrogensulfate
AU2003279337A1 (en) Direct process for the manufacture of tetraalkylammonium tetrafluoroborate-containing electrolyte compositions
WO2005037198A3 (en) Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
WO2006126081A3 (en) Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors
HK1078087A1 (en) Process for the preparation of (s,s)-cis-2-benzhydryl-3- benzylaminoquinuclidine
WO2006066950A3 (de) Tricyclische aminoalkohole, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
RS20070095A (en) Alkyliden-tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents
ZA200404475B (en) Novel crystalline forms of meloxicam and the preparation and interconversion methods thereof.
EP1670894B8 (en) Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
TW200510323A (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
AU2003252467A1 (en) Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
AU2002367890A1 (en) Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate
AU2003245880A1 (en) Process for the preparation of thioalkylamine derivatives
ZA200309288B (en) Process for the isolation of crystalline imipenem.
EP1436279B8 (en) Chemical compounds
AU2003225714A1 (en) Process for making perylene pigment compositions
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
AU2003202255A1 (en) Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
AU2003290403A1 (en) Process for the preparation of high quality 3,3',4,4'-tetraminobiphenyl
AU2003235132A1 (en) Honey, novel honey composition and process for producing the same
AU2003200836A1 (en) Method for the preparation of matairesinol
AU2003289566A1 (en) Preparation method of 1,5-dimethyltetralin
AU2003258637A1 (en) Process for the preparation of doped pentasil-type zeolite using doped seeds
EP1386911A3 (de) Verfahren zur Herstellung von Acyloxybenzolsulfonaten

Legal Events

Date Code Title Description
FA Abandonment or withdrawal